Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99m Tc-HMPAO

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hwang, Do Won ^a,b   Choi, Hongyoon ^a,b   Jang, Su Chul ^c,d   Yoo, Min Young ^a   Park, Ji Yong ^a   Choi, Na Eun ^a   Oh, Hyun Jeong ^a,b   Ha, Seunggyun ^a,b   Lee, Yun Sang ^a,b   Jeong, Jae Min ^a   Gho, Yong Song ^c   Lee, Dong Soo ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; CYTOLOGY; EXOSOME; MACROPHAGE; MOUSE; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; STAINING;

ANIMALS; CELL LINE; DRUG CARRIERS; EXOSOMES; MACROPHAGES; MICE; MICE, INBRED BALB C; RADIOPHARMACEUTICALS; STAINING AND LABELING; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84945282625     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15636     Document Type: Article

References (36)

1. Sun, D. et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev 65, 342-347 (2013).
2. Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78, 838-848 (2010).
3. Pan, B. T., Johnstone, R. M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967-978 (1983).
4. Thery, C., Zitvogel, L., Amigorena, S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2, 569-579 (2002).
5. Lakkaraju, A., Rodriguez-Boulan, E. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol 18, 199-209 (2008).
6. Lakhal, S., Wood, M. J. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 33, 737-741 (2011).
7. van Dommelen, S. M. et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 161, 635-644 (2012).
8. Zhuang, X. et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19, 1769-1779 (2011).
9. Hood, J. L., San, R. S., Wickline, S. A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71, 3792-3801 (2011).
10. Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat biotechnol 29, 341-345 (2011).
11. Ohno, S. et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21, 185-191 (2013).
12. Escudier, B. et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3, 10 (2005).
13. Hao, S., Moyana, T., Xiang, J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm 22, 692-703 (2007).
14. Jang, S. C. et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7, 7698-7710 (2013).
15. Segura, E. et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106, 216-223 (2005).
16. Théry, C., Amigorena, S., Raposo, G., Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 3. 22, 21-23. 22. 29 (2006).
17. Haney, M. J. et al. Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases. PLoS One 8, e61852 (2013).
18. Parolini, I. et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284, 34211-34222 (2009).
19. Takahashi, Y. et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165, 77-84 (2013).
20. Lai, C. P. et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 28, 483-494 (2014).
21. Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M. W., Anchordoquy, T. J. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199, 145-155 (2015).
22. Morishita, M. et al. Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice. J Pharm Sci 104, 705-713 (2015).
23. Peters, A. M. et al. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet 2, 946-949 (1986).
24. Sun, D. M. et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18, 1606-1614 (2010).
25. Tian, Y. et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35, 2383-2390 (2014).
26. Pegtel, D. M. et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107, 6328-6333 (2010).
27. De La Pena et al. Artificial exosomes as tools for basic and clinical immunology. J Immunol Methods 344, 121-132 (2009).
28. Goins, B. et al. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 34, 2160-2168 (1993).
29. Rudolph, A. S., Klipper, R. W., Goins, B., Phillips, W. T. In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc Natl Acad Sci USA 88, 10976-10980 (1991).
30. Bassa, P. et al. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control. Nucl Med Biol 21, 963-967 (1994).
31. Becker, W., Borner, W., Borst, U. 99mTc hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results. Nucl Med Commun 9, 831-842 (1988).
32. Saunderson, S. C., Dunn, A. C., Crocker, P. R., McLellan, A. D. CD169 mediates the capture of exosomes in spleen and lymph node. Blood 123, 208-216 (2014).
33. Mirahmadi, N., Babaei, M. H., Vali, A. M., Dadashzadeh, S. Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice. Int J Pharm 383, 7-13 (2010).
34. Lucignani, G. et al. In vivo metabolism and kinetics of 99mTc-HMPAO. Eur J Nucl Med 16, 249-255 (1990).
35. Peters, A. M. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 24, 110-127 (1994).
36. El-Andaloussi, S. et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7, 2112-2126 (2012).